Form 8-K - Current report:
SEC Accession No. 0001193125-25-130620
Filing Date
2025-05-29
Accepted
2025-05-29 16:06:35
Documents
12
Period of Report
2025-05-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d16794d8k.htm   iXBRL 8-K 33739
  Complete submission text file 0001193125-25-130620.txt   147882

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20250529.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20250529_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20250529_pre.xml EX-101.PRE 11272
15 EXTRACTED XBRL INSTANCE DOCUMENT d16794d8k_htm.xml XML 3680
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 251003331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)